Benzylidenemalononitrile derivatives as substrates and inhibitors of a new NAD(P)H dehydrogenase of erythrocytes. Purification and crystallisation of two forms of the enzyme.
Using the powerful lachrymator (2-chlorobenzylidene)malononitrile as electron acceptor, two types of NAD(P)H dehydrogenases have been isolated from human blood. Crystallisation of the homogenous enzymes was performed in 50% polyethylene glycol solution. The enzymes (average molecular weight 18 000) are composed of only one polypeptide chain and have a very similar amino acid composition. B-side stereospecificity was determined with respect to the cofactor by gas chromatography-mass spectrometry for the reductase. Besides (2-chlorobenzylidene)malononitrile, 2,6-dichloroindophenol, methylene blue, 4-benzoquinone, FMN and FAD are also reduced using NADH or NADPH as hydrogen donor with the rates decreasing in the given order. Reduction of methemoglobin is observed only upon addition of methylene blue, FMN or FAD as carriers. (2-Chlorobenzylidene)malononitrile reduction is inhibited by most of the compounds known to be decouplers of oxidative phosphorylation.
D000596:Amino Acids / Q000032:analysis; D003460:Crystallization; D004912:Erythrocytes / Q000201:enzymology*; D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D007527:Isoenzymes / Q000097:blood / Q000302:isolation & purification; D007700:Kinetics; D008970:Molecular Weight; D009247:NADH, NADPH Oxidoreductases / Q000097:blood* / Q000302:isolation & purification; D009570:Nitriles / Q000494:pharmacology*; D013329:Structure-Activity Relationship; D013379:Substrate Specificity; D009763:o-Chlorobenzylidenemalonitrile / Q000494:pharmacology*
D000596:Amino Acids; D007527:Isoenzymes; D009570:Nitriles; D009763:o-Chlorobenzylidenemalonitrile; D009247:NADH, NADPH Oxidoreductases